SafeBeat Achieves SOC 2 Type 2 Compliance SafeBeat is proud to announce that it has achieved SOC 2 Type 2 compliance, demonstrating our ongoing commitment to the security, privacy, and reliability of

SafeBeat Receives Supplement Award for UCSF Phase II SBIR Grant. Advancing Dr. Margaret Ferrari’s Career Development.   SafeBeat has been awarded a supplement award as part of its Phase Il SBIR

The SafeBeat Research team proudly participated in this year’s AF Symposium in Boston, commemorating three decades of pioneering advancements in atrial fibrillation (AF) care. The milestone event

SafeBeat Awarded $2M SBIR Grant to Advance AI-based ECG Analysis for Mobile Therapeutic Monitoring of Atrial Fibrillation Patients: Clinical Study at University of California San Francisco   SafeBeat

Dr. Rachita Navara expressed her pride in representing #HRX2023 as she highlighted the significance of having a dedicated conference for heart rhythm innovation within the field of EP cardiology. She

Thrilled to share the highlights of our CEO, Dr. Rachita Navara, MD, FACC as she played a pivotal role in shaping the event’s dynamic discussions. Dr. Navara not only wrapped up HRX as a

Dr. Kunj Patel and Dr. Rachita Navara immersed themselves in the latest advancements in digital health. They have been a part of this thrilling convergence of innovation, technology, and healthcare,

CEO, Dr. Rachita Navara, a prominent member of the ACC EP council, was featured in a special podcast episode dedicated to Atrial Fibrillation (AFib) Awareness Month. The podcast offered an insightful

CEO, Dr. Rachita Navara, and CTO, Dr. Kunj Patel, took the stage as featured panel speakers. The event was an exciting opportunity that delved into the world of healthcare innovation. Dr. Rachita

Dr. Rachita Navara, CEO and cofounder of Safebeat Rx, had an informative webinar on Atrial Fibrillation (AFib) management, treatment and prevention for patients and families.  Her presentation aimed